Increasing Coverage in Mass Drug Administration for Lymphatic Filariasis Elimination in an Urban Setting: a Study of Malindi Town, Kenya

被引:39
作者
Njomo, Doris W. [1 ]
Mukoko, Dunstan A. [2 ]
Nyamongo, Nipher K. [1 ]
Karanja, Joan [3 ]
机构
[1] Kenya Med Res Inst KEMRI, Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya
[2] Minist Hlth, Div Vector Borne & Neglected Trop Dis, Nairobi, Kenya
[3] Minist Hlth, Malindi Dist Hosp, Malindi, Kenya
基金
比尔及梅琳达.盖茨基金会;
关键词
DIETHYLCARBAMAZINE; PROGRAM; ALBENDAZOLE; IVERMECTIN; INFECTION; INDIA;
D O I
10.1371/journal.pone.0083413
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Implementation of Mass Drug Administration (MDA) in urban settings is an obstacle to Lymphatic Filariasis (LF) elimination. No urban-specific guidelines on MDA in urban areas exist. Malindi district urban area had received 4 MDA rounds by the time the current study was implemented. Programme data showed average treatment coverage of 28.4% (2011 MDA), far below recommended minimum of 65-80%. Methods: To identify, design and test strategies for increased treatment coverage in urban areas, a quasi-experimental study was conducted in Malindi urban area. Three sub-locations with lowest treatment coverage in 2011 MDA were purposively selected. In the pre-test phase, 947 household heads sampled using systematic random method were interviewed for quantitative data. For qualitative data, 12 Focus Group Discussions (FGDs) with single sex adult and youth male and female groups and 3 with community drug distributors (CDDs) were conducted. Forty in-depth interviews with opinion leaders and self-administered questionnaires with District Public Health officers purposively selected were carried out. The quantitative data were analyzed using SPSS version 16 and statistical significance assessed by x(2) test. The qualitative data were analyzed manually according to study's themes. Results and Discussion: The identified strategies were implemented prior to and during 2012 MDA in two sub-locations (experimental) while in the third (control), usual MDA strategies were applied. In the post-test phase, 2012 MDA coverage in experimental and control sub-locations was comparatively assessed for effect of the newly designed strategies on urban MDA. Results indicated improved treatment coverage in experimental sub-locations, 77.1% in Shella and 66.0% in Barani. Central (control) sub-location also attained high coverage, 70.4% indicating average treatment coverage of 71%. Conclusion: The identified strategies contributed to increased treatment coverage in experimental sites and should be applied in urban areas. Due to closeness of sites, spillover effects may have contributed to increased coverage in the control site.
引用
收藏
页数:9
相关论文
共 50 条
[41]   Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India [J].
Nandha, B. ;
Krishnamoorthy, K. ;
Jambulingam, P. .
HEALTH EDUCATION RESEARCH, 2013, 28 (04) :591-598
[42]   Cost-effectiveness of vector control for supplementing mass drug administration for eliminating lymphatic filariasis in India [J].
Shepard, Donald S. ;
Lwin, Aung K. ;
Pulikkottil, Sunish I. ;
Kalimuthu, Mariapillai ;
Arunachalam, Natarajan ;
Tyagi, Brij K. ;
White, Graham B. .
PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (12)
[43]   WILL MASS DRUG ADMINISTRATION ELIMINATE LYMPHATIC FILARIASIS? EVIDENCE FROM NORTHERN COASTAL TANZANIA [J].
Parker, Melissa ;
Allen, Tim .
JOURNAL OF BIOSOCIAL SCIENCE, 2013, 45 (04) :517-545
[44]   Frequency and Clinical Significance of Localized Adverse Events following Mass Drug Administration for Lymphatic Filariasis in an Endemic Area in South India [J].
Kuttiatt, Vijesh Sreedhar ;
Somani, Roopali K. ;
Swaminathan, Subramanian ;
Krishnamoorthy, Kaliannagounder ;
Weil, Gary J. ;
Purushothaman, Jambulingam .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2020, 102 (01) :96-99
[45]   Impact of Three Rounds of Mass Drug Administration on Lymphatic Filariasis in Areas Previously Treated for Onchocerciasis in Sierra Leone [J].
Koroma, Joseph B. ;
Sesay, Santigie ;
Sonnie, Mustapha ;
Hodges, Mary H. ;
Sahr, Foday ;
Zhang, Yaobi ;
Bockarie, Moses J. .
PLOS NEGLECTED TROPICAL DISEASES, 2013, 7 (06)
[46]   Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India [J].
Babu, BV ;
Rath, K ;
Kerketta, AS ;
Swain, BK ;
Mishra, S ;
Kar, SK .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2006, 100 (05) :464-469
[47]   Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis [J].
Gyapong, JO ;
Chinbuah, MA ;
Gyapong, M .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2003, 8 (12) :1093-1101
[48]   Beyond business as usual for lymphatic filariasis mass drug administration in hotspot districts [J].
de Souza, Dziedzom K. ;
Sumboh, Jeffrey G. ;
Laryea, Nii A. ;
Asiedu, Odame ;
Alomatu, Bright ;
Mensah, Sedzro K. ;
Otchere, Joseph ;
Opare, Joseph Larbi ;
Ahorlu, Collins S. .
INTERNATIONAL HEALTH, 2025,
[49]   Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya [J].
Njomo, Doris W. ;
Kimani, Bridget W. ;
Kibe, Lydiah W. ;
Okoyo, Collins ;
Omondi, Wyckliff P. ;
Sultani, Hadley M. .
PLOS NEGLECTED TROPICAL DISEASES, 2020, 14 (12) :1-21
[50]   Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration [J].
McLure, Angus ;
Graves, Patricia M. ;
Lau, Colleen ;
Shaw, Callum ;
Glass, Kathryn .
EPIDEMICS, 2022, 40